Endocrinology

General Hospital Medicine

Questions discussed in this category

Do 5HT4 agonists such as Metoclopramide actually lead to improvement in symptoms for patients with diabetes related gastroparesis?

1 Answer available

What is your approach to IV fluid management for the treatment of hypercalcemia of malignancy?

Is there an advantage between saline and LR?

1 Answer available

What is your approach to the use of GLP-1 agonists in older adults with diabetes with or at risk of sarcopenia?

3 Answers available

How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?

2 Answers available

When can we consider deferring an insulin drip in patients with hypertriglyceridemia-induced pancreatitis?

If the patient does not have underlying diabetes, do the benefits of an insulin drip for this indication outweigh the risks?

2 Answers available

How many days prior to elective major surgery do you recommend holding oral GLP 1 R agonist therapy?

4 Answers available

What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?

Do you find it helpful to monitor for treatment response, resolution, and/or recurrence?

1 Answer available

Would you start octreotide in a patient with suspected sulfonyurea overdose but without frank hypoglycemia?

1 Answer available

Should long-acting subcutaneous insulin be started upfront in addition to regular insulin infusion for patients with diabetic ketoacidosis?

4 Answers available

Has your management of severe hyponatremia changed after a recent observational study described higher in-hospital mortality for sodium correction of <6 mEq/L compared to 6-10 mEq/L in the first 24 hours?

Seethapathy et al., PMID 38320180

5 Answers available

In patients with confirmed hypercortisolism with a high/normal unsuppressed ACTH who have both a pituitary adenoma and adrenal adenoma identified on imaging, can you reliably use DHEA-S to determine the source of cortisol production?

2 Answers available

Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?

2 Answers available

Papers discussed in this category

The American journal of medicine, 2016-05

Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.

Clinical journal of the American Society of Nephrology : CJASN, 2018-07-06

Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.

Journal of critical care, 2023 May 13

Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes.

The Journal of urology, 1992-06

Functional obstructive uropathy: a significant factor in the hyponatremia of psychogenic polydipsia?

The Journal of clinical endocrinology and metabolism, 2012-09

Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.

Journal of the Endocrine Society, 2019-05-01

A Retrospective Study of Early vs Delayed Home Dose Basal Insulin in the Acute Management of Diabetic Ketoacidosis.

Current diabetes reviews, 2021

Evaluation of Early Administration of Insulin Glargine in the Acute Management of Diabetic Ketoacidosis.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2015 May 25

Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study.

Journal of clinical and diagnostic research : JCDR, 2015 May 01

Effectiveness of Insulin Glargine on Recovery of Patients with Diabetic Ketoacidosis: A Randomized Controlled Trial.

Diabetes, obesity & metabolism, 2022 Dec 20

Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial.

International journal of pancreatology : official journal of the International Association of Pancreatology, 1991 Nov-Dec

Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2023 Feb 27

The SQuID protocol (subcutaneous insulin in diabetic ketoacidosis): Impacts on ED operational metrics.

Diabetes care, 2022 Feb 01

Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis.

Diabetologia, 2024 Jun 22

Hyperglycaemic crises in adults with diabetes: a consensus report.

Journal of hospital medicine, 2025 Jul 21

Putting SQuID on the menu: A subcutaneous insulin protocol for diabetic ketoacidosis.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2024 Sep 23

SQuID (subcutaneous insulin in diabetic ketoacidosis) II: Clinical and operational effectiveness.

Diabetes research and clinical practice, 2021 Mar 08

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.

Journal of diabetes, 2025 Jun

Monitoring Sarcopenia With Incretin Receptor Activator Treatment.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2024 Oct 29

Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.

Endocrinology

General Hospital Medicine

Questions discussed in this category

Papers discussed in this category

Related Topics in Endocrinology